Share Price and Basic Stock Data
Last Updated: November 12, 2025, 6:13 pm
| PEG Ratio | 2.33 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Goyal Associates Ltd operates in the Non-Banking Financial Company (NBFC) sector, focusing on providing financial services. The company reported a market capitalization of ₹5.35 Cr and a share price of ₹1.01. Revenue trends indicate fluctuating sales, with a notable peak of ₹1.26 Cr in March 2023, followed by a decline to ₹0.93 Cr by September 2023. The trailing twelve months (TTM) revenue stood at ₹2.10 Cr, reflecting a decrease compared to the ₹3.41 Cr reported for the fiscal year ending March 2023. In the fiscal year 2024, sales increased slightly to ₹3.75 Cr, yet projections for fiscal year 2025 suggest a drop to ₹2.63 Cr. The operating profit margin (OPM) has shown variability, with a low of 0.79% in March 2023 and a recovery to 36.73% by March 2025. These revenue fluctuations highlight the company’s challenges in maintaining consistent growth, typical for the volatile NBFC sector.
Profitability and Efficiency Metrics
Goyal Associates Ltd reported a net profit of ₹0.56 Cr, with a remarkable return on equity (ROE) of 16.9% and a return on capital employed (ROCE) of 17.4%. The company’s profitability metrics reveal an operating profit of ₹0.95 Cr for the fiscal year ending March 2025, showcasing improved operational efficiency compared to prior years. The company’s interest coverage ratio (ICR) stood at 13.47x, indicating strong ability to cover interest expenses, which is above the typical sector standard. However, the cash conversion cycle (CCC) was reported at 22.21 days, a significant reduction from the previous years, suggesting improved efficiency in managing working capital. Despite these positive metrics, the operating profit margin (OPM) fluctuated significantly, indicating potential volatility in expense management, particularly as it dipped to 0.79% in March 2023.
Balance Sheet Strength and Financial Ratios
The balance sheet of Goyal Associates Ltd indicates a total liability of ₹8.48 Cr against total assets of ₹8.48 Cr, reflecting a balanced financial position. The company’s equity capital was reported at ₹5.29 Cr, with reserves showing a positive shift to ₹0.21 Cr in March 2025, a notable recovery from negative reserves in previous years. The debt-to-equity ratio stands at 0.19, suggesting a conservative leverage position compared to typical sector levels. Key financial ratios reveal a price-to-book value (P/BV) ratio of 1.38x, indicating a reasonable valuation relative to its book value. The current ratio is strong at 3.77, demonstrating good short-term liquidity. However, the company should remain vigilant about its liquidity management and operational efficiency to sustain these positive financial metrics moving forward.
Shareholding Pattern and Investor Confidence
The shareholding structure of Goyal Associates Ltd reflects significant public ownership, with 95.26% of shares held by the public as of March 2025. The promoters’ stake has decreased slightly to 4.72% during the same period, indicating a gradual dilution of control. The presence of domestic institutional investors (DIIs) is minimal at 0.01%, which could suggest limited institutional interest in the company. The total number of shareholders grew to 27,516 by March 2025, up from 8,368 in September 2022, signaling increasing retail investor confidence. However, the low institutional interest may pose challenges in terms of liquidity and market perception. The high public ownership could also indicate a lack of confidence from institutional investors, which may impact the company’s ability to raise capital in future expansions.
Outlook, Risks, and Final Insight
Goyal Associates Ltd faces a mixed outlook based on current financial data. Strengths include a robust return on equity and capital employed, alongside a strong interest coverage ratio, suggesting operational efficiency and profitability potential. However, risks remain, including revenue volatility, as evidenced by fluctuating sales and operating profit margins, which could impact investor confidence. The company’s high public ownership and low institutional participation may hinder its ability to attract larger investments. In a scenario where the company manages to stabilize its revenue streams and improve expense management, it may enhance profitability and attract institutional interest. Conversely, continued volatility in sales and expenses could lead to diminished investor confidence and potential liquidity challenges, necessitating careful strategic planning to navigate the evolving financial landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Goyal Associates Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 11.3 Cr. | 1.13 | 1.91/0.89 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 11.3 Cr. | 1.13 | 11.5/1.03 | 33.4 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 472 Cr. | 144 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.1 Cr. | 16.5 | 37.9/15.0 | 11.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 43.9 Cr. | 97.5 | 180/90.0 | 23.4 | 238 | 1.03 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,083.41 Cr | 472.31 | 113.22 | 518.32 | 0.21% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.56 | 0.78 | 0.09 | 1.26 | 0.98 | 0.93 | 0.93 | 0.92 | 0.81 | 0.44 | 0.89 | 0.49 | 0.28 |
| Expenses | 0.34 | 0.50 | 0.06 | 1.25 | 0.70 | 0.67 | 0.65 | 0.62 | 0.57 | 0.28 | 0.53 | 0.31 | 0.25 |
| Operating Profit | 0.22 | 0.28 | 0.03 | 0.01 | 0.28 | 0.26 | 0.28 | 0.30 | 0.24 | 0.16 | 0.36 | 0.18 | 0.03 |
| OPM % | 39.29% | 35.90% | 33.33% | 0.79% | 28.57% | 27.96% | 30.11% | 32.61% | 29.63% | 36.36% | 40.45% | 36.73% | 10.71% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 |
| Interest | 0.03 | 0.04 | 0.00 | 0.02 | 0.04 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 |
| Depreciation | 0.03 | 0.03 | 0.00 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| Profit before tax | 0.16 | 0.21 | 0.03 | -0.05 | 0.19 | 0.20 | 0.20 | 0.24 | 0.19 | 0.11 | 0.31 | 0.25 | 0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 26.32% | 0.00% | 25.00% | 4.17% | 0.00% | 0.00% | 0.00% | 48.00% | 0.00% |
| Net Profit | 0.16 | 0.21 | 0.02 | -0.05 | 0.14 | 0.20 | 0.15 | 0.24 | 0.18 | 0.11 | 0.31 | 0.13 | 0.01 |
| EPS in Rs | 0.03 | 0.04 | 0.00 | -0.01 | 0.03 | 0.04 | 0.03 | 0.05 | 0.04 | 0.02 | 0.07 | 0.02 | 0.00 |
Last Updated: August 19, 2025, 2:25 pm
Below is a detailed analysis of the quarterly data for Goyal Associates Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.28 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Mar 2025) to 0.28 Cr., marking a decrease of 0.21 Cr..
- For Expenses, as of Jun 2025, the value is 0.25 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Mar 2025) to 0.25 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.18 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.15 Cr..
- For OPM %, as of Jun 2025, the value is 10.71%. The value appears to be declining and may need further review. It has decreased from 36.73% (Mar 2025) to 10.71%, marking a decrease of 26.02%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.12 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.12 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.25 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.24 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 48.00% (Mar 2025) to 0.00%, marking a decrease of 48.00%.
- For Net Profit, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.12 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.00. The value appears to be declining and may need further review. It has decreased from 0.02 (Mar 2025) to 0.00, marking a decrease of 0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 1:01 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.35 | 0.45 | 0.18 | 0.14 | 0.61 | 6.65 | 3.62 | 1.17 | 1.52 | 3.41 | 3.75 | 2.63 | 2.10 |
| Expenses | 0.48 | 0.46 | 0.25 | 0.17 | 0.67 | 7.28 | 3.42 | 1.00 | 1.73 | 2.43 | 2.65 | 1.68 | 1.37 |
| Operating Profit | -0.13 | -0.01 | -0.07 | -0.03 | -0.06 | -0.63 | 0.20 | 0.17 | -0.21 | 0.98 | 1.10 | 0.95 | 0.73 |
| OPM % | -37.14% | -2.22% | -38.89% | -21.43% | -9.84% | -9.47% | 5.52% | 14.53% | -13.82% | 28.74% | 29.33% | 36.12% | 34.76% |
| Other Income | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.12 | 0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.10 | 0.09 | 0.08 | 0.06 |
| Depreciation | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.12 | 0.16 | 0.18 | 0.12 | 0.11 |
| Profit before tax | -0.17 | -0.03 | -0.07 | -0.03 | -0.06 | -0.63 | 0.20 | 0.06 | -0.44 | 0.72 | 0.84 | 0.87 | 0.68 |
| Tax % | 5.88% | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% | 15.00% | 33.33% | 0.00% | 16.67% | 25.00% | 13.79% | |
| Net Profit | -0.18 | -0.01 | -0.07 | -0.03 | -0.06 | -0.63 | 0.16 | 0.03 | -0.45 | 0.59 | 0.63 | 0.74 | 0.56 |
| EPS in Rs | -0.04 | -0.00 | -0.01 | -0.01 | -0.01 | -0.13 | 0.03 | 0.01 | -0.10 | 0.13 | 0.13 | 0.14 | 0.11 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 94.44% | -600.00% | 57.14% | -100.00% | -950.00% | 125.40% | -81.25% | -1600.00% | 231.11% | 6.78% | 17.46% |
| Change in YoY Net Profit Growth (%) | 0.00% | -694.44% | 657.14% | -157.14% | -850.00% | 1075.40% | -206.65% | -1518.75% | 1831.11% | -224.33% | 10.68% |
Goyal Associates Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | -6% |
| 3 Years: | 20% |
| TTM: | -42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 54% |
| 5 Years: | 36% |
| 3 Years: | 54% |
| TTM: | -27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 3:40 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 41.71 | 0.00 | 0.00 | 0.00 | 341.07 | 194.85 | 17.14 | 31.20 | 2.40 | 137.01 | 40.88 | 22.21 |
| Inventory Days | 587.56 | 478.28 | 6,778.57 | 8,395.00 | 845.58 | 53.83 | 56.93 | 0.00 | ||||
| Days Payable | 0.00 | 0.00 | 5,214.29 | 0.00 | 0.00 | 150.72 | 18.98 | |||||
| Cash Conversion Cycle | 629.28 | 478.28 | 1,564.29 | 8,395.00 | 1,186.65 | 97.96 | 55.09 | 31.20 | 2.40 | 137.01 | 40.88 | 22.21 |
| Working Capital Days | -1,574.71 | -1,143.67 | 2,190.00 | 6,413.57 | 1,250.57 | 92.76 | 51.42 | 65.51 | -273.75 | 35.32 | -95.39 | 824.37 |
| ROCE % | -4.39% | -0.72% | -2.24% | -1.01% | -2.04% | -24.32% | 8.47% | 2.96% | -6.80% | 20.84% | 22.57% | 17.37% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.16 | 0.13 | 0.12 | -0.10 | 0.01 |
| Diluted EPS (Rs.) | 0.14 | 0.13 | 0.12 | -0.10 | 0.01 |
| Cash EPS (Rs.) | 0.16 | 0.17 | 0.15 | -0.06 | 0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.04 | 0.69 | 0.55 | 0.43 | 0.53 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.04 | 0.69 | 0.55 | 0.43 | 0.53 |
| Revenue From Operations / Share (Rs.) | 0.49 | 0.79 | 0.72 | 0.32 | 0.24 |
| PBDIT / Share (Rs.) | 0.20 | 0.23 | 0.20 | -0.04 | 0.03 |
| PBIT / Share (Rs.) | 0.17 | 0.19 | 0.17 | -0.07 | 0.02 |
| PBT / Share (Rs.) | 0.16 | 0.17 | 0.14 | -0.09 | 0.01 |
| Net Profit / Share (Rs.) | 0.13 | 0.13 | 0.12 | -0.09 | 0.01 |
| PBDIT Margin (%) | 40.51 | 29.71 | 28.42 | -13.85 | 15.04 |
| PBIT Margin (%) | 35.87 | 24.82 | 23.60 | -22.05 | 10.33 |
| PBT Margin (%) | 32.86 | 22.43 | 20.60 | -29.53 | 5.28 |
| Net Profit Margin (%) | 28.10 | 16.81 | 17.03 | -29.53 | 4.45 |
| Return on Networth / Equity (%) | 13.40 | 19.40 | 22.22 | -22.04 | 2.08 |
| Return on Capital Employeed (%) | 14.99 | 23.54 | 27.49 | -15.95 | 4.66 |
| Return On Assets (%) | 8.70 | 10.41 | 11.60 | -8.30 | 0.77 |
| Total Debt / Equity (X) | 0.19 | 0.35 | 0.47 | 0.97 | 1.29 |
| Asset Turnover Ratio (%) | 0.36 | 0.67 | 0.65 | 0.25 | 0.24 |
| Current Ratio (X) | 3.77 | 2.70 | 2.14 | 1.54 | 1.54 |
| Quick Ratio (X) | 3.77 | 2.70 | 2.14 | 1.54 | 1.54 |
| Interest Coverage Ratio (X) | 13.47 | 12.40 | 9.48 | -1.85 | 2.98 |
| Interest Coverage Ratio (Post Tax) (X) | 10.34 | 8.01 | 6.68 | -2.95 | 1.88 |
| Enterprise Value (Cr.) | 8.48 | 9.36 | 14.19 | 9.24 | 18.94 |
| EV / Net Operating Revenue (X) | 3.23 | 2.49 | 4.16 | 6.10 | 16.24 |
| EV / EBITDA (X) | 7.97 | 8.40 | 14.65 | -44.00 | 107.99 |
| MarketCap / Net Operating Revenue (X) | 2.88 | 2.20 | 3.83 | 5.05 | 14.05 |
| Price / BV (X) | 1.38 | 2.54 | 5.00 | 3.77 | 6.58 |
| Price / Net Operating Revenue (X) | 2.88 | 2.20 | 3.83 | 5.05 | 14.06 |
| EarningsYield | 0.09 | 0.07 | 0.04 | -0.05 | 0.00 |
After reviewing the key financial ratios for Goyal Associates Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 0.16, marking an increase of 0.03.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 0.14, marking an increase of 0.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 3. It has decreased from 0.17 (Mar 24) to 0.16, marking a decrease of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.04. It has increased from 0.69 (Mar 24) to 1.04, marking an increase of 0.35.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.04. It has increased from 0.69 (Mar 24) to 1.04, marking an increase of 0.35.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.49. It has decreased from 0.79 (Mar 24) to 0.49, marking a decrease of 0.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 0.23 (Mar 24) to 0.20, marking a decrease of 0.03.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.17. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.17, marking a decrease of 0.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.16, marking a decrease of 0.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 2. There is no change compared to the previous period (Mar 24) which recorded 0.13.
- For PBDIT Margin (%), as of Mar 25, the value is 40.51. This value is within the healthy range. It has increased from 29.71 (Mar 24) to 40.51, marking an increase of 10.80.
- For PBIT Margin (%), as of Mar 25, the value is 35.87. This value exceeds the healthy maximum of 20. It has increased from 24.82 (Mar 24) to 35.87, marking an increase of 11.05.
- For PBT Margin (%), as of Mar 25, the value is 32.86. This value is within the healthy range. It has increased from 22.43 (Mar 24) to 32.86, marking an increase of 10.43.
- For Net Profit Margin (%), as of Mar 25, the value is 28.10. This value exceeds the healthy maximum of 10. It has increased from 16.81 (Mar 24) to 28.10, marking an increase of 11.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.40. This value is below the healthy minimum of 15. It has decreased from 19.40 (Mar 24) to 13.40, marking a decrease of 6.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.99. This value is within the healthy range. It has decreased from 23.54 (Mar 24) to 14.99, marking a decrease of 8.55.
- For Return On Assets (%), as of Mar 25, the value is 8.70. This value is within the healthy range. It has decreased from 10.41 (Mar 24) to 8.70, marking a decrease of 1.71.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has decreased from 0.35 (Mar 24) to 0.19, marking a decrease of 0.16.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.36. It has decreased from 0.67 (Mar 24) to 0.36, marking a decrease of 0.31.
- For Current Ratio (X), as of Mar 25, the value is 3.77. This value exceeds the healthy maximum of 3. It has increased from 2.70 (Mar 24) to 3.77, marking an increase of 1.07.
- For Quick Ratio (X), as of Mar 25, the value is 3.77. This value exceeds the healthy maximum of 2. It has increased from 2.70 (Mar 24) to 3.77, marking an increase of 1.07.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.47. This value is within the healthy range. It has increased from 12.40 (Mar 24) to 13.47, marking an increase of 1.07.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has increased from 8.01 (Mar 24) to 10.34, marking an increase of 2.33.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8.48. It has decreased from 9.36 (Mar 24) to 8.48, marking a decrease of 0.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.23. This value exceeds the healthy maximum of 3. It has increased from 2.49 (Mar 24) to 3.23, marking an increase of 0.74.
- For EV / EBITDA (X), as of Mar 25, the value is 7.97. This value is within the healthy range. It has decreased from 8.40 (Mar 24) to 7.97, marking a decrease of 0.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.88. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 2.88, marking an increase of 0.68.
- For Price / BV (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 1.38, marking a decrease of 1.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.88. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 2.88, marking an increase of 0.68.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.09, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Goyal Associates Ltd:
- Net Profit Margin: 28.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.99% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.4% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.07 (Industry average Stock P/E: 113.22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 28.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 401, Phoenix Complex, Waghodia Road, Vadodra Gujarat 390019 | info.goyalass@gmail.com www.goyalassociateslimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vuppala Naga Malleshwa Rao | Non Exe.Non Ind.Director |
| Mr. Vikram Singh Thakur | Ind. Non-Executive Director |
| Mr. Hasmukh Prajapati | Ind. Non-Executive Director |
| Mr. Harish Sharma | Ind. Non-Executive Director |